ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Acepodia Biotech, Inc.
Acepodia Biotech, Inc.
Brooklyn ImmunoTherapeutics, LLC
Dana-Farber Cancer Institute
Fate Therapeutics
Mie University
Brooklyn ImmunoTherapeutics, LLC
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)